James Morgan Cunningham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ebolavirus | 6 | 2021 | 263 | 1.530 |
Why?
|
| Receptors, Virus | 5 | 2018 | 649 | 1.270 |
Why?
|
| Viral Envelope Proteins | 8 | 2018 | 636 | 1.240 |
Why?
|
| Virus Internalization | 5 | 2018 | 502 | 1.020 |
Why?
|
| Lassa virus | 1 | 2018 | 97 | 0.620 |
Why?
|
| Avian leukosis virus | 2 | 2007 | 25 | 0.560 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2021 | 428 | 0.540 |
Why?
|
| Mutant Proteins | 1 | 2017 | 500 | 0.500 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1793 | 0.410 |
Why?
|
| Cathepsin B | 2 | 2017 | 82 | 0.400 |
Why?
|
| Epidemics | 1 | 2017 | 523 | 0.380 |
Why?
|
| Avian Proteins | 2 | 2007 | 80 | 0.360 |
Why?
|
| Vero Cells | 3 | 2018 | 485 | 0.360 |
Why?
|
| Cholesterol | 2 | 2018 | 2919 | 0.360 |
Why?
|
| Retroviridae Infections | 1 | 2007 | 151 | 0.300 |
Why?
|
| Gene Products, env | 1 | 2007 | 263 | 0.290 |
Why?
|
| Sulfhydryl Compounds | 1 | 2007 | 298 | 0.280 |
Why?
|
| Membrane Fusion | 2 | 2004 | 276 | 0.250 |
Why?
|
| Cathepsins | 1 | 2005 | 241 | 0.240 |
Why?
|
| Mink Cell Focus-Inducing Viruses | 1 | 2003 | 3 | 0.230 |
Why?
|
| Leukemia Virus, Feline | 1 | 2003 | 12 | 0.230 |
Why?
|
| Cysteine | 1 | 2007 | 873 | 0.220 |
Why?
|
| Endosomes | 2 | 2005 | 520 | 0.220 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 563 | 0.210 |
Why?
|
| Cell Line | 9 | 2021 | 16000 | 0.200 |
Why?
|
| Protein Folding | 1 | 2004 | 840 | 0.180 |
Why?
|
| Lassa Fever | 1 | 2018 | 97 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2020 | 437 | 0.150 |
Why?
|
| Esters | 1 | 2018 | 210 | 0.150 |
Why?
|
| Adamantane | 1 | 2018 | 173 | 0.150 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 407 | 0.150 |
Why?
|
| Protein Stability | 1 | 2018 | 556 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2007 | 2556 | 0.140 |
Why?
|
| Cell Fusion | 2 | 2007 | 297 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 3771 | 0.120 |
Why?
|
| Virulence | 1 | 2017 | 1333 | 0.110 |
Why?
|
| Antiviral Agents | 2 | 2018 | 2987 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.110 |
Why?
|
| Cricetinae | 3 | 2014 | 2475 | 0.110 |
Why?
|
| Models, Molecular | 2 | 2018 | 5451 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2017 | 5023 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2017 | 914 | 0.100 |
Why?
|
| Marburgvirus | 1 | 2011 | 20 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 3848 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2014 | 693 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1480 | 0.090 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2011 | 279 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2916 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4208 | 0.080 |
Why?
|
| Polymers | 1 | 2014 | 1621 | 0.070 |
Why?
|
| Animals | 11 | 2018 | 168770 | 0.070 |
Why?
|
| Transfection | 1 | 2014 | 5895 | 0.070 |
Why?
|
| Virion | 2 | 2005 | 433 | 0.070 |
Why?
|
| Cathepsin L | 1 | 2005 | 74 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2005 | 94 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2005 | 190 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1900 | 0.060 |
Why?
|
| Leukemia Virus, Murine | 1 | 2003 | 117 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5535 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2014 | 1905 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 1088 | 0.050 |
Why?
|
| Exocytosis | 1 | 2003 | 354 | 0.050 |
Why?
|
| Crystallization | 1 | 2003 | 525 | 0.050 |
Why?
|
| Cats | 1 | 2003 | 1000 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2003 | 442 | 0.050 |
Why?
|
| Neocortex | 1 | 2004 | 400 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 1978 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2003 | 23406 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 3177 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2256 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 2012 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 667 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2020 | 698 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2004 | 3749 | 0.040 |
Why?
|
| Mice | 6 | 2014 | 81202 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 1783 | 0.040 |
Why?
|
| Humans | 12 | 2021 | 744376 | 0.030 |
Why?
|
| HIV | 1 | 2003 | 1604 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2004 | 4010 | 0.030 |
Why?
|
| Virus Replication | 1 | 2003 | 2535 | 0.030 |
Why?
|
| Mutation | 2 | 2018 | 29786 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2003 | 2266 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2804 | 0.030 |
Why?
|
| Androstenes | 1 | 2014 | 170 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 818 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1771 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2020 | 1058 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 1409 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4464 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1520 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13814 | 0.020 |
Why?
|
| Endocytosis | 1 | 2014 | 985 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 18111 | 0.020 |
Why?
|
| Haplorhini | 1 | 2010 | 552 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3773 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19233 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2726 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2010 | 758 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12952 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9340 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2004 | 12209 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 3524 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16367 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2014 | 4162 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2004 | 214 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16692 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2571 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2003 | 337 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 411 | 0.010 |
Why?
|
| Biological Products | 1 | 2011 | 860 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 1865 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2004 | 645 | 0.010 |
Why?
|
| DNA | 1 | 2014 | 7294 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 871 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 1115 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 1988 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9384 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12073 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2418 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 3024 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3617 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9735 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14561 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9445 | 0.000 |
Why?
|